Skip to main content
Erschienen in: Journal of Clinical Immunology 8/2023

18.09.2023 | Original Article

Tuberculosis and Bacillus Calmette-Guérin Disease in Patients with Chronic Granulomatous Disease: an Experience from a Tertiary Care Center in North India

verfasst von: Pandiarajan Vignesh, Archan Sil, Ridhima Aggarwal, Wrik Laha, Sanjib Mondal, Manpreet Dhaliwal, Saniya Sharma, Rakesh Kumar Pilania, Ankur Kumar Jindal, Deepti Suri, Sunil Sethi, Amit Rawat, Surjit Singh

Erschienen in: Journal of Clinical Immunology | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Chronic granulomatous disease (CGD) is a phagocytic defect characterized by recurrent bacterial and fungal infections. We report clinical profile of patients with CGD and mycobacterial infections in a cohort from North India. A review of clinical and laboratory records was carried out for patients with CGD registered at our center between 1990 and 2021. Of the 99 patients with CGD, 22 had mycobacterial infections—Mycobacterium tuberculosis and M. bovis-BCG in 11 each. Among the children with M. bovis-BCG infection, 6 had localized and 5 had disseminated BCG disease. Median age at onset of symptoms and diagnosis of BCG disease was 5 months and 15 months, respectively. While disseminated forms of BCG were noted only in CYBB defect, none of the patients with NCF1 defect developed complications due to BCG vaccine. A recurring radiological feature was left axillary lymph node calcification, which was present in around 50% of CGD patients with BCG infections. Of 11 patients with tuberculosis, pulmonary, pleuro-pulmonary, abdominal, and disseminated forms were present in 6, 1, 2, and 2, respectively. Median age at onset of symptoms and diagnosis of tuberculosis was 129 months and 130 months, respectively. Molecular defects were identified in CYBB (5), NCF1 (4), and CYBA (1). Incidence of tuberculosis and BCG-related complications in patients with CGD is higher than the normal population. Screening for CGD is warranted in any patient with adverse reactions to BCG vaccination, calcification of left axillary lymph node, and persistent, recurrent or disseminated forms of tuberculosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Berendes H, Bridges RA, Good RA. A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med. 1957 May;40(5):309–12.PubMed Berendes H, Bridges RA, Good RA. A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med. 1957 May;40(5):309–12.PubMed
2.
Zurück zum Zitat Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease: report on a National Registry of 368 Patients. Medicine. 2000;79(3):155–69.CrossRefPubMed Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease: report on a National Registry of 368 Patients. Medicine. 2000;79(3):155–69.CrossRefPubMed
4.
Zurück zum Zitat Conti F, Lugo-Reyes SO, Blancas Galicia L, He J, Aksu G, Borges de Oliveira E, et al. Mycobacterial disease in patients with chronic granulomatous disease: a retrospective analysis of 71 cases. J Allergy Clin Immunol. 2016;138(1):241–248.e3.CrossRefPubMed Conti F, Lugo-Reyes SO, Blancas Galicia L, He J, Aksu G, Borges de Oliveira E, et al. Mycobacterial disease in patients with chronic granulomatous disease: a retrospective analysis of 71 cases. J Allergy Clin Immunol. 2016;138(1):241–248.e3.CrossRefPubMed
5.
Zurück zum Zitat Lee PPW, Chan KW, Jiang L, Chen T, Li C, Lee TL, et al. Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. J Pediatr Infect Dis. 2008;27(3):224–30.CrossRef Lee PPW, Chan KW, Jiang L, Chen T, Li C, Lee TL, et al. Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. J Pediatr Infect Dis. 2008;27(3):224–30.CrossRef
6.
Zurück zum Zitat Deffert C, Schäppi MG, Pache JC, Cachat J, Vesin D, Bisig R, et al. Bacillus Calmette-Guerin infection in NADPH oxidase deficiency: defective mycobacterial sequestration and granuloma formation. Behr MA, editor. PLoSPathog. 2014;10(9):e1004325. Deffert C, Schäppi MG, Pache JC, Cachat J, Vesin D, Bisig R, et al. Bacillus Calmette-Guerin infection in NADPH oxidase deficiency: defective mycobacterial sequestration and granuloma formation. Behr MA, editor. PLoSPathog. 2014;10(9):e1004325.
7.
Zurück zum Zitat Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity. J Allergy Clin Immunol: In Practice. 2019;7(6):1763–70. Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity. J Allergy Clin Immunol: In Practice. 2019;7(6):1763–70.
8.
Zurück zum Zitat Rawat A, Vignesh P, Sudhakar M, Sharma M, Suri D, Jindal A, et al. Clinical, immunological, and molecular profile of chronic granulomatous disease: a multi-centric study of 236 patients from India. Front Immunol. 2021;25(12):625320.CrossRef Rawat A, Vignesh P, Sudhakar M, Sharma M, Suri D, Jindal A, et al. Clinical, immunological, and molecular profile of chronic granulomatous disease: a multi-centric study of 236 patients from India. Front Immunol. 2021;25(12):625320.CrossRef
9.
Zurück zum Zitat Li T, Zhou X, Ling Y, Jiang N, Ai J, Wu J, et al. Genetic and clinical profiles of disseminated bacillus Calmette-Guérin disease and chronic granulomatous disease in China. Front Immunol. 2019;29(10):73.CrossRef Li T, Zhou X, Ling Y, Jiang N, Ai J, Wu J, et al. Genetic and clinical profiles of disseminated bacillus Calmette-Guérin disease and chronic granulomatous disease in China. Front Immunol. 2019;29(10):73.CrossRef
10.
Zurück zum Zitat Ariga T, Sakiyama Y, Tomizawa K, Imajoh-Ohmi S, Kanegasaki S, Matsumoto S. A newly recognized point mutation in the cytochrome b558 heavy chain gene replacing alanine57 by glutamic acid, in a patient with cytochrome b positive X-linked chronic granulomatous disease. Eur J Pediatr. 1993;152(6):469–72.CrossRefPubMed Ariga T, Sakiyama Y, Tomizawa K, Imajoh-Ohmi S, Kanegasaki S, Matsumoto S. A newly recognized point mutation in the cytochrome b558 heavy chain gene replacing alanine57 by glutamic acid, in a patient with cytochrome b positive X-linked chronic granulomatous disease. Eur J Pediatr. 1993;152(6):469–72.CrossRefPubMed
11.
Zurück zum Zitat Roos D, van Leeuwen K, Hsu AP, Priel DL, Begtrup A, Brandon R, et al. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells Mol Dis. 2021;90:102587.CrossRefPubMed Roos D, van Leeuwen K, Hsu AP, Priel DL, Begtrup A, Brandon R, et al. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells Mol Dis. 2021;90:102587.CrossRefPubMed
12.
Zurück zum Zitat Roos D, van Leeuwen K, Hsu AP, Priel DL, Begtrup A, Brandon R, et al. Hematologically important mutations: the autosomal forms of chronic granulomatous disease (third update). Blood Cells Mol Dis. 2021;92:102596.CrossRefPubMed Roos D, van Leeuwen K, Hsu AP, Priel DL, Begtrup A, Brandon R, et al. Hematologically important mutations: the autosomal forms of chronic granulomatous disease (third update). Blood Cells Mol Dis. 2021;92:102596.CrossRefPubMed
13.
Zurück zum Zitat Vignesh P, Sharma M, Pilania RK, Shandilya JK, Kaur A, Goel S, et al. Myriad faces of chronic granulomatous disease: all in an Indian family with novel CYBB defect. J Clin Immunol. 2019;39(6):611–5.CrossRefPubMed Vignesh P, Sharma M, Pilania RK, Shandilya JK, Kaur A, Goel S, et al. Myriad faces of chronic granulomatous disease: all in an Indian family with novel CYBB defect. J Clin Immunol. 2019;39(6):611–5.CrossRefPubMed
14.
Zurück zum Zitat Kuhns DB, Hsu AP, Sun D, Lau K, Fink D, Griffith P, et al. NCF1 (p47phox)–deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysis. Blood Adv. 2019;3(2):136–47.CrossRefPubMedPubMedCentral Kuhns DB, Hsu AP, Sun D, Lau K, Fink D, Griffith P, et al. NCF1 (p47phox)–deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysis. Blood Adv. 2019;3(2):136–47.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Pilania RK, Prithvi A, Nambiyar K, Gupta K, Rawat A. Revisiting fatal granulomatous disease of childhood through an autopsy: still lethal in the developing world! J Clin Immunol. 2019;39(3):241–4.CrossRefPubMed Pilania RK, Prithvi A, Nambiyar K, Gupta K, Rawat A. Revisiting fatal granulomatous disease of childhood through an autopsy: still lethal in the developing world! J Clin Immunol. 2019;39(3):241–4.CrossRefPubMed
16.
Zurück zum Zitat Bustamante J, Arias AA, Vogt G, Picard C, Galicia LB, Prando C, et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol. 2011;12(3):213–21.CrossRefPubMedPubMedCentral Bustamante J, Arias AA, Vogt G, Picard C, Galicia LB, Prando C, et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol. 2011;12(3):213–21.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Lau YL, Chan GC, Ha SY, Hui YF, Yuen KY. The role of phagocytic respiratory burst in host defense against Mycobacterium tuberculosis. Clin Infect Dis. 1998;26(1):226–7.CrossRefPubMed Lau YL, Chan GC, Ha SY, Hui YF, Yuen KY. The role of phagocytic respiratory burst in host defense against Mycobacterium tuberculosis. Clin Infect Dis. 1998;26(1):226–7.CrossRefPubMed
18.
Zurück zum Zitat Movahedi M, Aghamohammadi A, Rezaei N, Shahnavaz N, BabaeiJandaghi A, Farhoudi A, et al. Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian Primary Immunodeficiency Registry. Int Arch Allergy Immunol. 2004;134(3):253–9.CrossRefPubMed Movahedi M, Aghamohammadi A, Rezaei N, Shahnavaz N, BabaeiJandaghi A, Farhoudi A, et al. Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian Primary Immunodeficiency Registry. Int Arch Allergy Immunol. 2004;134(3):253–9.CrossRefPubMed
19.
Zurück zum Zitat Bustamante J, Aksu G, Vogt G, de Beaucoudrey L, Genel F, Chapgier A, et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol. 2007;120(1):32–8.CrossRefPubMed Bustamante J, Aksu G, Vogt G, de Beaucoudrey L, Genel F, Chapgier A, et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol. 2007;120(1):32–8.CrossRefPubMed
20.
Zurück zum Zitat Xu H, Tian W, Li SJ, Zhang LY, Liu W, Zhao Y, et al. Clinical and molecular features of 38 children with chronic granulomatous disease in Mainland China. J Clin Immunol. 2014;34(6):633–41.CrossRefPubMed Xu H, Tian W, Li SJ, Zhang LY, Liu W, Zhao Y, et al. Clinical and molecular features of 38 children with chronic granulomatous disease in Mainland China. J Clin Immunol. 2014;34(6):633–41.CrossRefPubMed
21.
Zurück zum Zitat Zhou Q, Hui X, Ying W, Hou J, Wang W, Liu D, et al. A cohort of 169 chronic granulomatous disease patients exposed to BCG vaccination: a retrospective study from a single center in Shanghai, China (2004–2017). J Clin Immunol. 2018;38(3):260–72.CrossRefPubMed Zhou Q, Hui X, Ying W, Hou J, Wang W, Liu D, et al. A cohort of 169 chronic granulomatous disease patients exposed to BCG vaccination: a retrospective study from a single center in Shanghai, China (2004–2017). J Clin Immunol. 2018;38(3):260–72.CrossRefPubMed
22.
Zurück zum Zitat Tajik S, Badalzadeh M, Fazlollahi MR, Houshmand M, Bazargan N, Movahedi M, et al. Genetic and molecular findings of 38 Iranian patients with chronic granulomatous disease caused by p47- phox defect. Scand J Immunol [Internet]. 2019;90(1) https://doi.org/10.1111/sji.12767. Tajik S, Badalzadeh M, Fazlollahi MR, Houshmand M, Bazargan N, Movahedi M, et al. Genetic and molecular findings of 38 Iranian patients with chronic granulomatous disease caused by p47- phox defect. Scand J Immunol [Internet]. 2019;90(1) https://​doi.​org/​10.​1111/​sji.​12767.
23.
Zurück zum Zitat León-Lara X, Campos-Murguía A, León-Cabral P, Tello-Mercado A, Salgado-Nesme N, de la Mora JD, et al. Disseminated tuberculosis in a patient with autosomal recessive p47phox chronic granulomatous disease. J Clin Immunol. 2021;41(6):1417–9.CrossRefPubMed León-Lara X, Campos-Murguía A, León-Cabral P, Tello-Mercado A, Salgado-Nesme N, de la Mora JD, et al. Disseminated tuberculosis in a patient with autosomal recessive p47phox chronic granulomatous disease. J Clin Immunol. 2021;41(6):1417–9.CrossRefPubMed
24.
Zurück zum Zitat Fattahi F, Badalzadeh M, Sedighipour L, Movahedi M, Fazlollahi MR, Mansouri SD, et al. Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease. J Clin Immunol. 2011;31(5):792–801.CrossRefPubMed Fattahi F, Badalzadeh M, Sedighipour L, Movahedi M, Fazlollahi MR, Mansouri SD, et al. Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease. J Clin Immunol. 2011;31(5):792–801.CrossRefPubMed
25.
Zurück zum Zitat Bakri FG, Martel C, Khuri-Bulos N, Mahafzah A, El-Khateeb MS, Al-Wahadneh AM, et al. First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families. J Clin Immunol. 2009;29(2):215–30.CrossRefPubMed Bakri FG, Martel C, Khuri-Bulos N, Mahafzah A, El-Khateeb MS, Al-Wahadneh AM, et al. First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families. J Clin Immunol. 2009;29(2):215–30.CrossRefPubMed
26.
Zurück zum Zitat Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8(3):e1001012.CrossRefPubMedPubMedCentral Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8(3):e1001012.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Trehan I, Mouayaxeng S, Nigogosyan MA. Axillary calcification due to bacillus Calmette-Guérin Vaccination. J Pediatr. 2020;223:218–9.CrossRefPubMed Trehan I, Mouayaxeng S, Nigogosyan MA. Axillary calcification due to bacillus Calmette-Guérin Vaccination. J Pediatr. 2020;223:218–9.CrossRefPubMed
30.
Zurück zum Zitat Yao Q, Zhou QH, Shen QL, Wang XC, Hu XH. Imaging characteristics of pulmonary BCG/TB infection in patients with chronic granulomatous disease. Sci Rep. 2022;12(1):11765.CrossRefPubMedPubMedCentral Yao Q, Zhou QH, Shen QL, Wang XC, Hu XH. Imaging characteristics of pulmonary BCG/TB infection in patients with chronic granulomatous disease. Sci Rep. 2022;12(1):11765.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Shrot S, Barkai G, Ben-Shlush A, Soudack M. BCGitis and BCGosis in children with primary immunodeficiency - imaging characteristics. PediatrRadiol. 2016;46(2):237–45. Shrot S, Barkai G, Ben-Shlush A, Soudack M. BCGitis and BCGosis in children with primary immunodeficiency - imaging characteristics. PediatrRadiol. 2016;46(2):237–45.
32.
Zurück zum Zitat Deffert C, Cachat J, Krause KH. Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections: NADPH oxidase and BCG infection. Cell Microbiol. 2014;16(8):1168–78.CrossRefPubMed Deffert C, Cachat J, Krause KH. Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections: NADPH oxidase and BCG infection. Cell Microbiol. 2014;16(8):1168–78.CrossRefPubMed
33.
Zurück zum Zitat Fekrvand S, Yazdani R, Olbrich P, Gennery A, Rosenzweig SD, Condino-Neto A, et al. Primary Immunodeficiency diseases and Bacillus Calmette-Guérin (BCG)-vaccine-derived complications: a systematic review. J Allergy Clin Immunol Pract. 2020;8(4):1371–86.CrossRefPubMed Fekrvand S, Yazdani R, Olbrich P, Gennery A, Rosenzweig SD, Condino-Neto A, et al. Primary Immunodeficiency diseases and Bacillus Calmette-Guérin (BCG)-vaccine-derived complications: a systematic review. J Allergy Clin Immunol Pract. 2020;8(4):1371–86.CrossRefPubMed
34.
Zurück zum Zitat Yadav RM, Dalvi A, Gupta M, Bargir UA, Shabrish S, Aluri J, et al. Spectrum of inborn errors of immunity in a cohort of 90 patients presenting with complications to BCG vaccination in India. Scand J Immunol. 2021;93(5):e13010.CrossRefPubMed Yadav RM, Dalvi A, Gupta M, Bargir UA, Shabrish S, Aluri J, et al. Spectrum of inborn errors of immunity in a cohort of 90 patients presenting with complications to BCG vaccination in India. Scand J Immunol. 2021;93(5):e13010.CrossRefPubMed
35.
Zurück zum Zitat SoyakAytekin E, Keskin A, Tan C, Yalçın E, Dogru D, Ozcelik U, et al. Differential diagnosis of primary immunodeficiency in patients with BCGitis and BCGosis: a single-centre study. Scand J Immunol. 2021;94(4):e13084.CrossRef SoyakAytekin E, Keskin A, Tan C, Yalçın E, Dogru D, Ozcelik U, et al. Differential diagnosis of primary immunodeficiency in patients with BCGitis and BCGosis: a single-centre study. Scand J Immunol. 2021;94(4):e13084.CrossRef
Metadaten
Titel
Tuberculosis and Bacillus Calmette-Guérin Disease in Patients with Chronic Granulomatous Disease: an Experience from a Tertiary Care Center in North India
verfasst von
Pandiarajan Vignesh
Archan Sil
Ridhima Aggarwal
Wrik Laha
Sanjib Mondal
Manpreet Dhaliwal
Saniya Sharma
Rakesh Kumar Pilania
Ankur Kumar Jindal
Deepti Suri
Sunil Sethi
Amit Rawat
Surjit Singh
Publikationsdatum
18.09.2023
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 8/2023
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-023-01581-w

Weitere Artikel der Ausgabe 8/2023

Journal of Clinical Immunology 8/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.